Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

4KW5

M. tuberculosis DprE1 in complex with inhibitor TCA1

Summary for 4KW5
Entry DOI10.2210/pdb4kw5/pdb
Related4FDN 4FDO 4FDP 4FEH 4FF6
DescriptorOxidoreductase, FLAVIN-ADENINE DINUCLEOTIDE, ethyl ({2-[(1,3-benzothiazol-2-ylcarbonyl)amino]thiophen-3-yl}carbonyl)carbamate, ... (6 entities in total)
Functional Keywordsalpha/beta fold, oxidoreductase, oxidoreductase-oxidoreductase inhibitor complex, oxidoreductase/oxidoreductase inhibitor
Biological sourceMycobacterium tuberculosis
Total number of polymer chains2
Total formula weight103107.27
Authors
Batt, S.M.,Besra, G.S.,Futterer, K. (deposition date: 2013-05-23, release date: 2013-07-10, Last modification date: 2023-09-20)
Primary citationWang, F.,Sambandan, D.,Halder, R.,Wang, J.,Batt, S.M.,Weinrick, B.,Ahmad, I.,Yang, P.,Zhang, Y.,Kim, J.,Hassani, M.,Huszar, S.,Trefzer, C.,Ma, Z.,Kaneko, T.,Mdluli, K.E.,Franzblau, S.,Chatterjee, A.K.,Johnson, K.,Mikusova, K.,Besra, G.S.,Futterer, K.,Jacobs, W.R.,Schultz, P.G.
Identification of a small molecule with activity against drug-resistant and persistent tuberculosis.
Proc.Natl.Acad.Sci.USA, 110:E2510-E2517, 2013
Cited by
PubMed Abstract: A cell-based phenotypic screen for inhibitors of biofilm formation in mycobacteria identified the small molecule TCA1, which has bactericidal activity against both drug-susceptible and -resistant Mycobacterium tuberculosis (Mtb) and sterilizes Mtb in vitro combined with rifampicin or isoniazid. In addition, TCA1 has bactericidal activity against nonreplicating Mtb in vitro and is efficacious in acute and chronic Mtb infection mouse models both alone and combined with rifampicin or isoniazid. Transcriptional analysis revealed that TCA1 down-regulates genes known to be involved in Mtb persistence. Genetic and affinity-based methods identified decaprenyl-phosphoryl-β-D-ribofuranose oxidoreductase DprE1 and MoeW, enzymes involved in cell wall and molybdenum cofactor biosynthesis, respectively, as targets responsible for the activity of TCA1. These in vitro and in vivo results indicate that this compound functions by a unique mechanism and suggest that TCA1 may lead to the development of a class of antituberculosis agents.
PubMed: 23776209
DOI: 10.1073/pnas.1309171110
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.612 Å)
Structure validation

227111

PDB entries from 2024-11-06

PDB statisticsPDBj update infoContact PDBjnumon